ZEALAND PHARMA A/S: Financial statements 2016
CVR: 20045078
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 234,778,000 and a net result of DKK -153,910,000 compared with DKK -113,957,000 the year before. That is an increase of 25.1% compared with the year before. The profit margin was -65.6%. Equity in the 2016 report amounted to DKK 278,194,000. The solvency ratio was 40%.
- Revenue
- DKK 234,778,000
- Profit/Loss
- DKK -153,910,000
- Equity
- DKK 278,194,000
- Total Assets
- DKK 694,626,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 234.8M | - | -153.9M | 278.2M | - |
| 2015 | 187.7M | 165.4M | -114M | 252.2M | - |
| 2014 | 153.8M | 140M | -65M | 252.8M | - |
Official annual report
Find more companies like ZEALAND PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
ZEALAND PHARMA A/S has published its interim report for the period July 1, 2016 to September 30, 2016.
ZEALAND PHARMA A/S has published its interim report for the period April 1, 2016 to June 30, 2016.
As of June 2, 2016, James Peter Arthur Benson has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2016 to March 31, 2016.
ZEALAND PHARMA A/S has published its annual report for 2015. Revenue came to DKK 187,677,000, and the net result was DKK -113,957,000.
As of April 19, 2016, Hanne Heidenheim Bak has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Helle Haxgart has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Helle Størum has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Christian Thorkildsen has joined the board of directors of ZEALAND PHARMA A/S.
As of April 19, 2016, Rasmus Just has joined the board of directors of ZEALAND PHARMA A/S.
About ZEALAND PHARMA A/S
ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.